A chemogenetic approach for dopamine imaging with tunable sensitivity.
Saved in:
| Title: | A chemogenetic approach for dopamine imaging with tunable sensitivity. |
|---|---|
| Authors: | Labouesse MA; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland.; Neuroscience Center Zurich, University and ETH Zürich, Zürich, Switzerland.; Department of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland., Wilhelm M; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland.; Institute for Neuroscience, ETH Zurich, Zurich, Switzerland., Kagiampaki Z; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland., Yee AG; Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO, USA., Denis R; Department of Pharmacology & Physiology, Faculty of Medicine, SNC and CIRCA Research groups, Université de Montréal, Montréal, QC, Canada.; Department of Neurosciences, Faculty of Medicine, SNC and CIRCA Research groups, Université de Montréal, Montréal, QC, Canada., Harada M; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland., Gresch A; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland., Marinescu AM; Department of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland., Otomo K; Department of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland., Curreli S; Optical Approaches to Brain Function Laboratory, Istituto Italiano di Tecnologia, Genova, Italy., Serratosa Capdevila L; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland., Zhou X; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland., Cola RB; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland., Ravotto L; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland., Glück C; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland., Cherepanov S; Institute of Cellular and Integrative Neuroscience, University of Strasbourg, Strasbourg, France., Weber B; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland.; Neuroscience Center Zurich, University and ETH Zürich, Zürich, Switzerland., Zhou X; Eli Lilly and Company, Indianapolis, IN, USA., Katner J; Eli Lilly and Company, Indianapolis, IN, USA., Svensson KA; Eli Lilly and Company, Indianapolis, IN, USA., Fellin T; Optical Approaches to Brain Function Laboratory, Istituto Italiano di Tecnologia, Genova, Italy., Trudeau LE; Department of Pharmacology & Physiology, Faculty of Medicine, SNC and CIRCA Research groups, Université de Montréal, Montréal, QC, Canada.; Department of Neurosciences, Faculty of Medicine, SNC and CIRCA Research groups, Université de Montréal, Montréal, QC, Canada., Ford CP; Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO, USA., Sych Y; Institute of Cellular and Integrative Neuroscience, University of Strasbourg, Strasbourg, France., Patriarchi T; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland. patriarchi@pharma.uzh.ch.; Neuroscience Center Zurich, University and ETH Zürich, Zürich, Switzerland. patriarchi@pharma.uzh.ch. |
| Source: | Nature communications [Nat Commun] 2024 Jul 02; Vol. 15 (1), pp. 5551. Date of Electronic Publication: 2024 Jul 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-024-49442-3 |
